These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8362516)

  • 1. Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetus.
    Dooren MC; Engelfriet CP
    Vox Sang; 1993; 65(1):59-61. PubMed ID: 8362516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of unexplained mild Rh (D) haemolytic disease in utero.
    Bromilow IM; Downing I; Walkinshaw SA; Welch CR; Duguid JK
    Transfus Med; 1995 Mar; 5(1):31-5. PubMed ID: 7767395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Rh antibodies in haemolytic disease of the newborn.
    Hadley AG; Kumpel BM
    Baillieres Clin Haematol; 1993 Jun; 6(2):423-44. PubMed ID: 8043933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental transport of maternal immunoglobulin G in pregnancies at risk of Rh (D) hemolytic disease of the newborn.
    Palfi M; Hildén JO; Gottvall T; Selbing A
    Am J Reprod Immunol; 1998 May; 39(5):323-8. PubMed ID: 9602250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gm typing, IgG subclasses of anti-Rh(D) and severity of hemolytic disease of the newborn.
    Alie-Daran SJ; Dugoujon JM; Fournie A
    Vox Sang; 1992; 62(2):127-8. PubMed ID: 1519368
    [No Abstract]   [Full Text] [Related]  

  • 6. IgG subclasses of anti-Rh(D) and haemolytic disease of the newborn.
    Eklund J; Jouppila P; Seppälä IJ
    Vox Sang; 1988; 55(1):51-2. PubMed ID: 3138818
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution of IgG subtypes in maternal anti-D sera and their prognostic value in Rh haemolytic disease of the new-born.
    Iyer YS; Kulkarni SV; Gupte SC
    Acta Haematol; 1992; 88(2-3):78-81. PubMed ID: 1466203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
    Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
    Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. About diminished transport of maternal IgG (RhD alloimmunization) to the fetus.
    Grozdea J; Alie-Daram S; Vergnes H; Brisson-Lougarre A; Calot M; Martin J; Fournie A
    Vox Sang; 1995; 68(2):134-5. PubMed ID: 7605505
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG
    Vox Sang; 1998; 74 Suppl 2():375-83. PubMed ID: 9704470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG
    Transpl Immunol; 2002 Aug; 10(2-3):191-8. PubMed ID: 12216949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [THE HUMAN PLACENTA IN ANTI RH ISOIMMUNIZATION. (COMPARATIVE STUDY BETWEEN THE HISTOLOGICAL AND MICROFLUOROSCOPIC ASPECTS)].
    DECECCO L; PAVONE G; ROLFINI G
    Quad Clin Ostet Ginecol; 1963 Oct; 18():675-82. PubMed ID: 14103066
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemolytic disease of the newborn.
    Lancet; 1989 Feb; 1(8634):361-2. PubMed ID: 2563513
    [No Abstract]   [Full Text] [Related]  

  • 15. PREVENTION OF RH-HAEMOLYTIC DISEASE: A THIRD REPORT.
    WOODROW JC; CLARKE CA; DONOHOE WT; FINN R; MCCONNELL RB; SHEPPARD PM; LEHANE D; RUSSELL SH; KULKE W; DURKIN CM
    Br Med J; 1965 Jan; 1(5430):279-83. PubMed ID: 14229706
    [No Abstract]   [Full Text] [Related]  

  • 16. Transplacental IgG subclass concentrations in pregnancies at risk of haemolytic disease of the newborn.
    Lubenko A; Contreras M; Rodeck CH; Nicolini U; Savage J; Chana H
    Vox Sang; 1994; 67(3):291-8. PubMed ID: 7863629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhesus haemolytic disease.
    Whittle MJ
    Arch Dis Child; 1992 Jan; 67(1 Spec No):65-8. PubMed ID: 1536591
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children.
    Pegoraro V; Urbinati D; Visser GHA; Di Renzo GC; Zipursky A; Stotler BA; Spitalnik SL
    PLoS One; 2020; 15(7):e0235807. PubMed ID: 32687543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decreasing Rhesus serum antibody titer in pregnancy with Rhesus constellation].
    Kölbl H; Riss P
    Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):285-6. PubMed ID: 3110000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti Rh 17 in a multigravida with Rh-D-/[symbol: see text] genotype resulting in haemolytic disease of the newborn.
    Davis SG; Aboud E
    Clin Exp Obstet Gynecol; 1998; 25(3):75. PubMed ID: 9856300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.